HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | A077157 | TEVA PHARMACEUTICALS USA
Highest NADAC/Unit
$0.0798
per ea
Lowest NADAC/Unit
$0.0621
per ea
Brand NDCs
0
Generic NDCs
9
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00093736810LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB | $0.0798 | EA | Generic | — | 2026-06-17 |
| 00093736898LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB | $0.0798 | EA | Generic | — | 2026-06-17 |
| 00093736856LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB | $0.0798 | EA | Generic | — | 2026-06-17 |
| 00093736998LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | $0.0755 | EA | Generic | — | 2026-06-17 |
| 00093736910LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | $0.0755 | EA | Generic | — | 2026-06-17 |
| 00093736956LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | $0.0755 | EA | Generic | — | 2026-06-17 |
Showing 6 of 9 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.